Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Shares Sold by Amalgamated Bank

Amalgamated Bank trimmed its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105,602 shares of the real estate investment trust’s stock after selling 1,884 shares during the quarter. Amalgamated Bank’s holdings in Sabra Healthcare REIT were worth $1,845,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Oppenheimer & Co. Inc. acquired a new position in shares of Sabra Healthcare REIT during the 1st quarter worth approximately $578,000. Autumn Glory Partners LLC raised its stake in shares of Sabra Healthcare REIT by 356.0% during the 1st quarter. Autumn Glory Partners LLC now owns 45,600 shares of the real estate investment trust’s stock worth $797,000 after buying an additional 35,600 shares during the period. Retirement Systems of Alabama raised its stake in shares of Sabra Healthcare REIT by 243.3% during the 1st quarter. Retirement Systems of Alabama now owns 987,655 shares of the real estate investment trust’s stock worth $17,254,000 after buying an additional 699,985 shares during the period. GAMMA Investing LLC raised its stake in shares of Sabra Healthcare REIT by 1,710.3% during the 1st quarter. GAMMA Investing LLC now owns 93,447 shares of the real estate investment trust’s stock worth $1,633,000 after buying an additional 88,285 shares during the period. Finally, Jefferies Financial Group Inc. acquired a new position in shares of Sabra Healthcare REIT during the 4th quarter worth approximately $348,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Up 0.8%

Shares of SBRA opened at $18.62 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. Sabra Healthcare REIT, Inc. has a one year low of $15.11 and a one year high of $20.03. The stock has a market capitalization of $4.43 billion, a price-to-earnings ratio of 31.55, a PEG ratio of 1.41 and a beta of 0.85. The stock has a 50 day moving average price of $17.91 and a 200 day moving average price of $17.32.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a return on equity of 5.14% and a net margin of 19.55%. The company had revenue of $183.54 million during the quarter, compared to analysts’ expectations of $180.23 million. During the same period in the prior year, the business earned $0.35 EPS. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a $0.30 dividend. The ex-dividend date was Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.45%. Sabra Healthcare REIT’s payout ratio is 203.39%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Scotiabank upped their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. Truist Financial boosted their price target on Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average target price of $19.67.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the business’s stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.10% of the stock is owned by insiders.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.